查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
RWE（真實世界證據）解決方案市場：2023-2028 年全球行業趨勢、份額、規模、增長、機遇和預測
市場調查報告書
商品編碼
1207169

RWE（真實世界證據）解決方案市場：2023-2028 年全球行業趨勢、份額、規模、增長、機遇和預測

Real-World Evidence Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

到 2022 年，全球真實證據解決方案市場將達到 16 億美元。 展望未來，IMARC Group 預測到 2028 年將達到 27 億美元，2023 年至 2028 年的增長率 (CAGR) 為 8.57%。

真實世界證據 (RWE) 是指通過真實世界數據 (RWD) 提供的關於醫療產品的使用和潛在益處或風險的臨床證據。 RWE 可以通過各種研究設計和分析產生，包括隨機試驗、大型簡單試驗、實用試驗和觀察性研究。 RWD 提供對患者群體真實世界治療模式的洞察，包括劑量、依從性、依從性、標籤外使用以及療效和安全性之間的平衡。 全球對 RWE 解決方案的需求也在不斷增長，因為它們可以幫助研究人員通過發現潛在患者和製定正確的臨床試驗納入標準來設計更好的臨床前試驗。

真實世界證據解決方案的市場趨勢

  • 為了獲得有關新產品安全性和有效性的準確清晰信息，對 RWE 解決方案的需求不斷增長，這是推動市場發展的關鍵因素之一。 此外，越來越需要這些解決方案來檢測複雜和共病患者使用中的各種反應、產品亞群效應和產品價值。 這與蓬勃發展的醫療保健行業一起推動了市場增長。 此外，RWE 越來越多地使用先進的分析和技術解決方案來加速臨床開發、商業化、加速創新和改善醫療保健結果，這也對市場產生了積極影響。 除此之外，多個國家正在實施各種政府特定舉措，以促進使用提供藥物和疫苗功效的 RWE 解決方案。 這一點，再加上從基於數量的護理到基於價值的護理的轉變，為行業投資者提供了有利可圖的增長機會。 除此之外，越來越多地採用數字化和以患者為中心的虛擬護理正在推動對 RWE 解決方案的需求。 此外，癌症、肥胖症和糖尿病等慢性病的患病率在全球範圍內呈上升趨勢。 與此同時，藥物開發的延遲增加以及隨之而來的開發成本的增加正在推動市場的增長。

主要市場細分

  • 在其全球真實世界證據解決方案市場報告中，IMARC Group 提供了 2023 年至 2028 年全球、區域和國家層面的預測，以及對每個子細分市場的主要趨勢的分析。 該報告根據成分、治療領域和最終用戶對市場進行分類。

按組件細分

  • 臨床設置數據
  • 聲明數據
  • 患者驅動的數據
  • 藥房數據
  • 其他

按治療領域細分

  • 腫瘤科
  • 免疫學
  • 神經區域
  • 循環區
  • 其他

最終用戶細分

  • 製藥公司、醫療設備製造商
  • 醫療保健付款人
  • 醫療保健提供者
  • 其他

按地區劃分

  • 北美
  • 美國
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳大利亞
  • 印度尼西亞
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

本報告中回答的關鍵問題

  • 全球真實世界證據解決方案市場迄今為止發生了怎樣的變化，未來幾年又將發生怎樣的變化？
  • COVID-19 對全球真實證據解決方案市場有何影響？
  • 主要的區域市場是什麼？
  • 基於組件的市場細分情況如何？
  • 按治療領域劃分的市場細分情況如何？
  • 最終用戶的市場細分情況如何？
  • 行業價值鏈中有哪些不同階段？
  • 該行業的主要驅動因素和挑戰是什麼？
  • 全球真實世界證據解決方案的市場結構和主要參與者是什麼？
  • 該行業的競爭程度如何？

內容

第一章前言

第 2 章研究方法和範圍

  • 調查的目的
  • 利益相關者
  • 數據源
    • 主要信息
    • 次要信息
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章執行摘要

第四章介紹

  • 概覽
  • 主要行業趨勢

第 5 章真實世界證據解決方案的全球市場

  • 市場概覽
  • 市場結果
  • COVID-19 的影響
  • 市場預測

第 6 章組件市場細分

  • 臨床站點數據
    • 市場趨勢
    • 市場預測
  • 聲明數據
    • 市場趨勢
    • 市場預測
  • 患者信息數據
    • 市場趨勢
    • 市場預測
  • 藥房數據
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章治療領域的市場細分

  • 腫瘤科
    • 市場趨勢
    • 市場預測
  • 免疫區域
    • 市場趨勢
    • 市場預測
  • 神經區域
    • 市場趨勢
    • 市場展望
  • 循環區
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章最終用戶市場細分

  • 製藥和醫療設備製造商
    • 市場趨勢
    • 市場預測
  • 醫療保健付款人
    • 市場趨勢
    • 市場預測
  • 醫療保健提供者
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章按區域劃分的市場細分

  • 北美
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場展望
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場展望
    • 日本
      • 市場趨勢
      • 市場展望
    • 印度
      • 市場趨勢
      • 市場展望
    • 韓國市場
      • 市場趨勢
      • 市場展望
    • 澳大利亞
      • 市場趨勢
      • 市場展望
    • 印度尼西亞
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場展望
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 意大利
      • 市場趨勢
      • 市場展望
    • 西班牙
      • 市場趨勢
      • 市場展望
    • 俄羅斯
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場展望
    • 墨西哥
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家/地區劃分的市場細分
    • 市場展望

第 10 章 SWOT 分析

  • 概覽
  • 強度
  • 弱點
  • 機會
  • 威脅

第11章價值鏈分析

第12章搬運工五力分析

  • 概覽
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章競爭格局

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • Aetion Inc.
    • Clinigen Limited
    • Flatiron Health Inc.（Roche Holding AG）
    • ICON plc
    • International Business Machines Corporation
    • IQVIA
    • Optum Inc.（UnitedHealth Group Incorporated）
    • Oracle Corporation
    • Parexel International Corporation
    • PPD Inc.（Thermo Fisher Scientific Inc.）
    • Sas Institute Inc.
    • Syneos Health
Product Code: SR1323A641_Report

The global real-world evidence solutions market size reached US$ 1.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.7 Billion by 2028, exhibiting a growth rate (CAGR) of 8.57% during 2023-2028.

Real-world evidence (RWE) refers to clinical evidence about the use and potential benefits or risks of medical products via real-world data (RWD). It can be produced via different study designs or analyses, including randomized trials, big simple trials, pragmatic trials, and observational studies. It provides insight into real-world treatment patterns in patient groups, including dosing, compliance, adherence, off-label use, and the balance between efficacy and safety. As it can also assist researchers in discovering possible patients and developing correct inclusion criteria for clinical trials, which can help them design better pre-trial studies, there is a rise in the demand for RWE solutions around the world.

Real-World Evidence Solutions Market Trends:

  • The growing demand for RWE solutions to get precise and clear information about the safety and efficacy of new products represents one of the key factors driving the market. Moreover, there is a rise in the demand for these solutions to detect varied reactions, product subpopulation effects, and product value when utilized by complex and comorbid patients. This, along with the burgeoning healthcare industry, is propelling the growth of the market. Additionally, the growing utilization of advanced analytics and technological solutions in RWE for clinical development, commercialization, speed innovation, and accelerating improvements in healthcare outcomes is positively influencing the market. Besides this, there are various initiatives undertaken by governments of several countries to promote the use of RWE solutions, which provide the efficacy of drugs and vaccines. This, coupled with a shift from volume to value-based care, is offering lucrative growth opportunities to industry investors. Apart from this, the growing adoption of digitalization and patient-centered virtual care is catalyzing the demand for RWE solutions. Furthermore, there is an increase in the prevalence of chronic diseases, such as cancer, obesity, and diabetes, across the globe. In line with this, the rising delays in drug development and the subsequent increase in development costs are bolstering the growth of the market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global real-world evidence solutions market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, therapeutic area and end user.

Breakup by Component:

  • Clinical Settings Data
  • Claims Data
  • Patient-Powered Data
  • Pharmacy Data
  • Others

Breakup by Therapeutic Area:

  • Oncology
  • Immunology
  • Neurology
  • Cardiovascular Disease
  • Others

Breakup by End User:

  • Pharmaceutical and Medical Device Companies
  • Healthcare Payers
  • Healthcare Providers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Aetion Inc., Clinigen Limited, Flatiron Health Inc. (Roche Holding AG), ICON plc, International Business Machines Corporation, IQVIA, Optum Inc. (UnitedHealth Group Incorporated), Oracle Corporation, Parexel International Corporation, PPD Inc. (Thermo Fisher Scientific Inc.), Sas Institute Inc. and Syneos Health.

Key Questions Answered in This Report:

  • How has the global real-world evidence solutions market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global real-world evidence solutions market?
  • What are the key regional markets?
  • What is the breakup of the market based on the component?
  • What is the breakup of the market based on the therapeutic area?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global real-world evidence solutions market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Real-World Evidence Solutions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Clinical Settings Data
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Claims Data
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Patient-Powered Data
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Pharmacy Data
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Therapeutic Area

  • 7.1 Oncology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Immunology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular Disease
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical and Medical Device Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Healthcare Payers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Healthcare Providers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Aetion Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Clinigen Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Flatiron Health Inc. (Roche Holding AG)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 ICON plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 International Business Machines Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 IQVIA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Optum Inc. (UnitedHealth Group Incorporated)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Oracle Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Parexel International Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 PPD Inc. (Thermo Fisher Scientific Inc.)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Sas Institute Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 SWOT Analysis
    • 14.3.12 Syneos Health
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Real-World Evidence Solutions Market: Major Drivers and Challenges
  • Figure 2: Global: Real-World Evidence Solutions Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Real-World Evidence Solutions Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Real-World Evidence Solutions Market: Breakup by Component (in %), 2022
  • Figure 5: Global: Real-World Evidence Solutions Market: Breakup by Therapeutic Area (in %), 2022
  • Figure 6: Global: Real-World Evidence Solutions Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Real-World Evidence Solutions Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Real-World Evidence Solutions (Clinical Settings Data) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Real-World Evidence Solutions (Clinical Settings Data) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Real-World Evidence Solutions (Claims Data) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Real-World Evidence Solutions (Claims Data) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Real-World Evidence Solutions (Patient-Powered Data) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Real-World Evidence Solutions (Patient-Powered Data) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Real-World Evidence Solutions (Pharmacy Data) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Real-World Evidence Solutions (Pharmacy Data) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Real-World Evidence Solutions (Other Components) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Real-World Evidence Solutions (Other Components) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Real-World Evidence Solutions (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Real-World Evidence Solutions (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Real-World Evidence Solutions (Immunology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Real-World Evidence Solutions (Immunology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Real-World Evidence Solutions (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Real-World Evidence Solutions (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Real-World Evidence Solutions (Cardiovascular Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Real-World Evidence Solutions (Cardiovascular Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Real-World Evidence Solutions (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Real-World Evidence Solutions (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Real-World Evidence Solutions (Pharmaceutical and Medical Device Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Real-World Evidence Solutions (Pharmaceutical and Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Real-World Evidence Solutions (Healthcare Payers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Real-World Evidence Solutions (Healthcare Payers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Real-World Evidence Solutions (Healthcare Providers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Real-World Evidence Solutions (Healthcare Providers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Real-World Evidence Solutions (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Real-World Evidence Solutions (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: North America: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: North America: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: United States: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: United States: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Canada: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Canada: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Asia-Pacific: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Asia-Pacific: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: China: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: China: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Japan: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Japan: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: India: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: India: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: South Korea: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: South Korea: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Australia: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Australia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Indonesia: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Indonesia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Others: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Europe: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Europe: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Germany: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Germany: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: France: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: France: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: United Kingdom: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: United Kingdom: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Italy: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Italy: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Spain: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Spain: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Russia: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Russia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Latin America: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Latin America: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Brazil: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Brazil: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Mexico: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Mexico: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Others: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Middle East and Africa: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Middle East and Africa: Real-World Evidence Solutions Market: Breakup by Country (in %), 2022
  • Figure 84: Middle East and Africa: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Global: Real-World Evidence Solutions Industry: SWOT Analysis
  • Figure 86: Global: Real-World Evidence Solutions Industry: Value Chain Analysis
  • Figure 87: Global: Real-World Evidence Solutions Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Real-World Evidence Solutions Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Real-World Evidence Solutions Market Forecast: Breakup by Component (in Million US$), 2023-2028
  • Table 3: Global: Real-World Evidence Solutions Market Forecast: Breakup by Therapeutic Area (in Million US$), 2023-2028
  • Table 4: Global: Real-World Evidence Solutions Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Real-World Evidence Solutions Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Real-World Evidence Solutions Market: Competitive Structure
  • Table 7: Global: Real-World Evidence Solutions Market: Key Players